Price Alert

Clover Health Investments... (CLOV)

NASDAQ: CLOV · Real-Time Price · USD

2.58

-0.04 (-1.53%)

At close: Aug 14, 2025, 3:59 PM

2.60

0.97%

After-hours: Aug 14, 2025, 07:59 PM EDT

Clover Health Investments Statistics

Share Statistics

Clover Health Investments has 508.92M shares outstanding. The number of shares has increased by 2.3% in one year.

Shares Outstanding	508.92M
Shares Change (YoY)	2.3%
Shares Change (QoQ)	-0.39%
Owned by Institutions (%)	21.25%
Shares Floating	467.51M
Failed to Deliver (FTD) Shares	27,539
FTD / Avg. Volume	0.3%

Short Selling Information

The latest short interest is 36.2M, so 7.11% of the outstanding shares have been sold short.

Short Interest	36.2M
Short % of Shares Out	7.11%
Short % of Float	8.93%
Short Ratio (days to cover)	3.33

Valuation Ratios

The PE ratio is -35.89 and the forward PE ratio is null. Clover Health Investments's PEG ratio is 0.45.

PE Ratio	-35.89
Forward PE	n/a
PS Ratio	1.13
Forward PS	0.5
PB Ratio	4.52
P/FCF Ratio	46.37
PEG Ratio	0.45

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Clover Health Investments.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.

Current Ratio	1.61
Quick Ratio	1.61
Debt / Equity	0
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$2.41M
Profits Per Employee	$-75.45K
Employee Count	570
Asset Turnover	2.36
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by 31.55% in the last 52 weeks. The beta is 1.92, so Clover Health Investments's price volatility has been higher than the market average.

Beta	1.92
52-Week Price Change	31.55%
50-Day Moving Average	2.91
200-Day Moving Average	3.5
Relative Strength Index (RSI)	28.15
Average Volume (20 Days)	9,309,637

Income Statement

In the last 12 months, Clover Health Investments had revenue of 1.37B and earned -43.01M in profits. Earnings per share was -0.09.

Revenue	1.37B
Gross Profit	364.8M
Operating Income	-45.75M
Net Income	-43.01M
EBITDA	-44.94M
EBIT	-46.27M
Earnings Per Share (EPS)	-0.09

Full Income Statement

Balance Sheet

The company has 194.54M in cash and 0 in debt, giving a net cash position of 194.54M.

Cash & Cash Equivalents	194.54M
Total Debt	n/a
Net Cash	n/a
Retained Earnings	-2.2B
Total Assets	574.99M
Working Capital	160.99M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 34.84M and capital expenditures -1.56M, giving a free cash flow of 33.29M.

Operating Cash Flow	34.84M
Capital Expenditures	-1.56M
Free Cash Flow	33.29M
FCF Per Share	0.07

Full Cash Flow Statement

Margins

Gross margin is 26.61%, with operating and profit margins of -3.34% and -3.14%.

Gross Margin	26.61%
Operating Margin	-3.34%
Pretax Margin	-3.37%
Profit Margin	-3.14%
EBITDA Margin	-3.28%
EBIT Margin	-3.34%
FCF Margin	2.43%

Dividends & Yields

CLOV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for CLOV is $4.1, which is 66.7% higher than the current price. The consensus rating is "Buy".

Price Target	$4.1
Price Target Difference	66.7%
Analyst Consensus	Buy
Analyst Count	3

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	0.38
Piotroski F-Score	2